UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 52

Sortiert nach

Maternal colonization with extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in term versus preterm pregnancies

International journal of gynecology and obstetrics, 2023-05, Vol.161 (2), p.447-454

2023

Volltextzugriff (PDF)

A simulation tool for modeling the influence of anatomy on information flow using discrete integrate and fire neurons

Journal of combinatorial optimization, 2008-04, Vol.15 (3), p.287-304

2008

Volltextzugriff (PDF)

A simulation tool for modeling the influence of anatomy on information flow using discrete integrate and fire neurons: Combinatorial Optimization in Data Mining

Journal of combinatorial optimization, 2008, Vol.15 (3), p.287-304

2008

Volltextzugriff (PDF)

A Large Scale Simulator Model of the Cortex and Information Theory Monitoring Tools

2007

Volltextzugriff (PDF)

Pretreatment Neutrophil‐to‐Lymphocyte Ratio in Metastatic Castration‐Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram

The oncologist (Dayton, Ohio), 2012-12, Vol.17 (12), p.1508-1514

2012

Volltextzugriff (PDF)

Post-operative dysphagia following ventral cervical approach: complication or side-effect? Retrospective analysis and review of the literature

British journal of neurosurgery, 2023-02, Vol.37 (1), p.86-89

2023

Volltextzugriff (PDF)

Long term follow-up of EGFR mutated NSCLC cases

Translational oncology, 2021-01, Vol.14 (1), p.100934-100934, Article 100934

2021

Volltextzugriff (PDF)

Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?

World journal of urology, 2014-02, Vol.32 (1), p.39-45

2014

Volltextzugriff (PDF)

Active Smoking May Negatively Affect Response Rate, Progression‐Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

The oncologist (Dayton, Ohio), 2014-01, Vol.19 (1), p.51-60

2014

Volltextzugriff (PDF)

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data

The oncologist (Dayton, Ohio), 2022-02, Vol.27 (1), p.e76-e84

2022

Volltextzugriff (PDF)

Metastatic Hormone Refractory Prostate Cancer: Recent Advances in Standard Treatment Paradigm, and Future Directions

American journal of clinical oncology, 2014-06, Vol.37 (3), p.289-296

2014

Volltextzugriff (PDF)

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

European journal of cancer (1990), 2012-05, Vol.48 (7), p.1031-1037

2012

Volltextzugriff (PDF)

3rd-line anaplastic lymphoma kinase (ALK) inhibitors (ALKi) in advanced non-small cell lung cancer (aNSCLC): Real-world comparison to non-ALKi therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21685-e21685

2020

Volltextzugriff (PDF)

Statins (ASIs) may improve the outcome of erlotinib as second line treatment (tx) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e18108-e18108

2012

Volltextzugriff (PDF)

The association between proton pump inhibitors (PPI) use for gastro-esophageal reflux disease (GERD) and lung cancer (LC): A nested case-control study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1562-1562

2017

Volltextzugriff (PDF)

Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non-metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Results of a prospective phase II study

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.14-14

2018

Volltextzugriff (PDF)

Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in patients (pts) with nonmetastatic, biochemically relapsed prostate cancer (BRPC): Results of the interim analysis of a prospective phase II study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16588-e16588

2017

Volltextzugriff (PDF)

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma

Clinical genitourinary cancer, 2016-10, Vol.14 (5), p.420-425

2016

Volltextzugriff (PDF)

Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e16051-e16051

2013

Volltextzugriff (PDF)

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?

Cancer Research and Treatment, 2016, 48(1), , pp.281-287

2016

Volltextzugriff (PDF)

Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx)

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.160-160

2013

Volltextzugriff (PDF)

Pretreatment (pre-tx) neutrophil to lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with ketoconazole (keto): Association with outcome and predictive model

Journal of clinical oncology, 2012-02, Vol.30 (5_suppl), p.37-37

2012

Volltextzugriff (PDF)

Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with ketoconazole

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e16068-e16068

2014

Volltextzugriff (PDF)

THE CURRENT APPROACH TO METASTATIC RENAL CELL CARCINOMA

הרפואה, 2015-08, Vol.154 (8), p.535

2015

Volltextzugriff (PDF)

THE CURRENT APPROACH TO ADVANCED LUNG CANCER

הרפואה, 2015-08, Vol.154 (8), p.521

2015

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(51)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(15)
Science & Technology
(15)
Life Sciences & Biomedicine
(14)
Oncology
(12)
Male
(9)
Retrospective Studies
(9)
Treatment Outcome
(8)
Female
(7)
Kidney Neoplasms - Drug Therapy
(7)
Middle Aged
(7)
Aged
(6)
Antineoplastic Agents - Therapeutic Use
(6)
Carcinoma, Renal Cell - Drug Therapy
(6)
Neoplasm Metastasis
(6)
Adult
(5)
Aged, 80 And Over
(5)
Outcome
(5)
Survival Rate
(5)
Disease-Free Survival
(4)
Indoles - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Maternal colonization with extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in term versus preterm pregnancies

A simulation tool for modeling the influence of anatomy on information flow using discrete integrate and fire neurons

A simulation tool for modeling the influence of anatomy on information flow using discrete integrate and fire neurons: Combinatorial Optimization in Data Mining

A Large Scale Simulator Model of the Cortex and Information Theory Monitoring Tools

Pretreatment Neutrophil‐to‐Lymphocyte Ratio in Metastatic Castration‐Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive Nomogram

Post-operative dysphagia following ventral cervical approach: complication or side-effect? Retrospective analysis and review of the literature

Long term follow-up of EGFR mutated NSCLC cases

Are bisphosphonates an indispensable tool in the era of targeted therapy for renal cell carcinoma and bone metastases?

Active Smoking May Negatively Affect Response Rate, Progression‐Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

ALK Inhibitors or Chemotherapy for Third Line in ALK-positive NSCLC? Real-world Data

Metastatic Hormone Refractory Prostate Cancer: Recent Advances in Standard Treatment Paradigm, and Future Directions

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

3rd-line anaplastic lymphoma kinase (ALK) inhibitors (ALKi) in advanced non-small cell lung cancer (aNSCLC): Real-world comparison to non-ALKi therapy

Statins (ASIs) may improve the outcome of erlotinib as second line treatment (tx) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC)

The association between proton pump inhibitors (PPI) use for gastro-esophageal reflux disease (GERD) and lung cancer (LC): A nested case-control study

Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non-metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Results of a prospective phase II study

Effect of PectaSol-C modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in patients (pts) with nonmetastatic, biochemically relapsed prostate cancer (BRPC): Results of the interim analysis of a prospective phase II study

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma

Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx)

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?

Influence of concurrent medications on PSA doubling time (PSADT) in patients (pts) with nonmetastatic biochemically relapsed prostate cancer (BRPC M0) after local therapy (tx)

Pretreatment (pre-tx) neutrophil to lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with ketoconazole (keto): Association with outcome and predictive model

Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate resistant prostate cancer (mCRPC) treated with ketoconazole

THE CURRENT APPROACH TO METASTATIC RENAL CELL CARCINOMA

THE CURRENT APPROACH TO ADVANCED LUNG CANCER

Suchergebnisse filtern